The expiry of a patent covering an active ingredient can create a significant commercial opportunity for manufacturers and distributors of crop-protection products. It does not, however, follow that every product containing that ingredient may be brought to market without further patent analysis.
Commercial crop-protection products frequently incorporate intellectual property extending beyond the active ingredient itself. Relevant patent rights may relate to particular combinations of compounds, formulations, crystal forms, concentration ranges, safeners, stabilisers, delivery systems, dosage regimes, or manufacturing processes. A proper freedom-to-operate assessment must therefore consider the product that will actually be manufactured, imported or sold, rather than the patent status of the active ingredient in isolation.
South African patent litigation provides a useful illustration. In Stauffer Chemical Company v Safsan Marketing and Distribution, the patent concerned herbicidal compositions comprising an active herbicidal compound together with an antidote or safener. The dispute required the Court to consider the composition of the allegedly infringing product against the wording and scope of the patent claims. The enquiry was directed to whether the product fell within those claims, rather than whether it produced broadly similar agricultural results.
The same analytical discipline applies when assessing a proposed market entry today. Patent ownership, legal status, remaining term and claim scope need to be considered against the technical characteristics of the proposed product. Depending on the circumstances, the review may extend beyond the active ingredient to its chemical form, combinations with other actives, formulation systems and particular functional components.
Freedom to operate must also be distinguished from patentability. A new product may incorporate technical improvements capable of attracting patent protection of their own, while still falling within the scope of an earlier patent held by another party. Patentability is concerned with whether an invention satisfies requirements such as novelty and inventive step. Freedom to operate addresses whether commercialisation of the product may infringe an existing patent right.
Regulatory approval introduces a separate enquiry. The Department of Agriculture’s 2026 Chemistry Data Requirements Guideline contains detailed requirements relating to technical material, chemical equivalence and formulated agricultural remedies under Act 36 of 1947. Compliance with the regulatory framework does not amount to patent clearance and should not be treated as confirmation that a product may be commercialised free of third-party IP rights.
The timing of the patent review can have significant commercial consequences. An assessment undertaken during product development may identify potential obstacles while formulation, sourcing and launch strategy remain capable of adjustment. Depending on the findings, a business may be able to redesign aspects of the product, investigate the validity or scope of a relevant patent, consider licensing options or align market entry with the expiry of an existing right.
The position becomes more difficult once expenditure has already been committed to trials, registration, manufacturing and distribution.
Patent expiry at active-ingredient level can therefore represent the beginning of a market-entry analysis rather than its conclusion. A broader review of the product and the surrounding patent landscape is required before substantial investment is committed to commercialisation.
KISCH IP advises crop-protection businesses on patentability, patent infringement and revocation proceedings, patent landscapes, freedom-to-operate assessments, Act 36 regulatory matters, market-entry strategy and related aspects of IP and Agricultural Law.
